Cancer Patients: We will commence a clinical trial in patients with recurrent or refractory head and neck cancer during 2008. We do not currently intend to conduct clinical trials in other cancers during 2008, and we do not maintain a registry of possible candidates. For information on other clinical trials, please visit MD Anderson (http://www.mdanderson.org/patients_public/clinical_trials/) or your local Cancer Center.

Other: For further information, contact J. Donald Payne, President, Nanospectra Biosciences, Inc., at DPayne@Nanospectra.com

Nanospectra Biosciences, Inc.
8285 El Rio Street, Suite 150
Houston, Texas 77054
(713) 842-2720
Fax (713) 440-9349